Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Hovione has once again solidified its position as a top employer.
Silicon Republic, October 2, 2020
Outsourced Pharma, April 2023
Bartolomeu de Gusmão award distinguishes innovation and protection of intellectual property
Innovation potential in profitable growth and financial strength
Google Chrome
Safari
Firefox
Edge